Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia

Author:

Gr�mayer Eva Renate,Schmidmeier Waltraud,Panzer Simon,Gadner Helmut

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine,Hematology

Reference14 articles.

1. Amadori S, Papa G, Avvisati G, Fenu S, Monarca B, Petti MC, Pulsoni A, Mandelli F (1984) Sequential combination of high dose ARA-C (HIDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma. Leuk Res 8 (4): 729?735

2. Capizzi RL, Cheng Y-C (1982) Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia. Med Pediatr Oncol (Suppl) 1: 221?226

3. Capizzi RL, Poole M, Cooper MR, Richard F, Stuart JJ, Jackson DV, White DR, Spurr CL, Hopkins JO, Muss HB, Rudnick SA, Wells R, Gabriel D, Ross D (1984) Treatment of poor risk acute leukemia with sequential high-dose ARA-C and Asparaginase. Blood 63: 694?700

4. Chu, MY, Fischer GA (1965) Comparative studies of leukemic cells sensitive and resistant to cytosine arabinoside. Biochem Pharmacol 14: 333?341

5. Drewinko B, Ho DHW, Barranco SC (1972) The effects of arabinosylcytosine on cultured human lymphoma cells. Cancer Res 32: 2737?2742

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3